Sensitized detection of inhibitory fragments and iterative development of non-peptidic protease inhibitors by dynamic ligation screening

Marco Florian Schmidt, Albert Isidro-Llobet, Michael Lisurek, Adeeb El-Dahshan, Jinzhi Tan, Rolf Hilgenfeld, Jörg Rademann

58 Zitate (Scopus)

Abstract

(Chemical Presented) A potential anti-SARS drug has been developed by dynamic ligation screening (DLS), by which nucleophilic fragments are directed to the protein's active site by reversible reaction with an aldehyde inhibitor. Their inhibitory effect is detected by competition with a fluorogenic enzyme substrate. With this concept, low-affinity fragments binding specifically to the active site are quickly identified in a functional enzyme assay.

OriginalspracheEnglisch
ZeitschriftAngewandte Chemie - International Edition
Jahrgang47
Ausgabenummer17
Seiten (von - bis)3275-3278
Seitenumfang4
ISSN1433-7851
DOIs
PublikationsstatusVeröffentlicht - 14.04.2008

Strategische Forschungsbereiche und Zentren

  • Forschungsschwerpunkt: Infektion und Entzündung - Zentrum für Infektions- und Entzündungsforschung Lübeck (ZIEL)

Coronavirus-Bezug

  • Forschung zu SARS-CoV-2 / COVID-19

Fingerprint

Untersuchen Sie die Forschungsthemen von „Sensitized detection of inhibitory fragments and iterative development of non-peptidic protease inhibitors by dynamic ligation screening“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren